TFAP2A

From WikiMD's WELLNESSPEDIA

TFAP2A is a gene that encodes a transcription factor protein in humans. This protein is part of the AP-2 family, which plays a critical role in development and differentiation of the cell. Mutations in this gene have been associated with various medical conditions, including Branchiooculofacial syndrome and Char syndrome.

Structure[edit]

The TFAP2A gene is located on the long (q) arm of chromosome 6 at position 24.3. The gene spans about 20 kilobases and consists of 7 exons. The encoded protein, AP-2 alpha, contains 437 amino acids and has a molecular weight of approximately 48 kDa.

Function[edit]

AP-2 alpha, the protein encoded by the TFAP2A gene, is a transcription factor that binds to a specific sequence in DNA, known as the GC-rich consensus sequence. This protein plays a crucial role in cell growth, differentiation, and apoptosis. It is also involved in the development of the face, limbs, and neural crest-derived tissues.

Clinical significance[edit]

Mutations in the TFAP2A gene can lead to various medical conditions. For instance, a mutation in this gene is the cause of Branchiooculofacial syndrome, a rare genetic disorder characterized by distinctive facial features, skin abnormalities, and hearing loss. Similarly, Char syndrome, a condition that affects the heart, face, and fingers, is also associated with mutations in the TFAP2A gene.

Research[edit]

Research on the TFAP2A gene and its encoded protein is ongoing, with studies focusing on its role in development and disease. Understanding the function and regulation of this gene could lead to new treatments for the conditions associated with its mutation.


References[edit]


External links[edit]

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.